<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Endotracheal tube cuff":1,
"Intubation":1,
"Tracheal rupture":1,
"Tracheomalacia":1,
"HNMEC":1,
"MEC":1,
"mucoepidermoid carcinoma":3,
"second primary malignancy":2,
"second primary tumor":1,
"131-iodine ablation":1,
"levothyroxine withdrawal":1,
"recombinant human thyroid-stimulating hormone":1,
"sialadenitis":1,
"thyroid cancer":64,
"bipaddled radial forearm free flap (RFFF) procedure":1,
"closure of tracheoesophageal fistula (TEF)":1,
"post-total laryngectomy":1,
"post-total pharyngolaryngectomy":1,
"tracheoesophageal fistula (TEF)":1,
"tracheoesophageal puncture (TEP)":1,
"central neck dissection":2,
"lymph node metastasis":7,
"Sorafenib":2,
"antiangiogenic agent":1,
"skin toxicity":1,
"urticaria":1,
"lymph node dissection":3,
"lymphatic metastasis":2,
"papillary thyroid carcinoma":38,
"thyroid isthmus":2,
"thyroid neoplasm":4,
"clinical target volume":1,
"intensity-modulated radiotherapy":1,
"lateralized cancer":1,
"nasopharyngeal carcinoma":1,
"organs at risk":1,
"Elderly":1,
"Endocrine therapy":1,
"Thyroid function":1,
"Thyroid surgery":2,
"Thyroid-stimulating hormone":2,
"acute pain":1,
"bilateral axillo-breast approach (BABA)":1,
"postoperative pain":1,
"robotic thyroid surgery":1,
"ropivacaine":1,
"interventional pathologist":1,
"rapid on-site evaluation":2,
"thyroid":27,
"ultrasound-guided fine needle aspiration":1,
"Hashimoto thyroiditis":1,
"ablation":2,
"low dose":1,
"radioiodine":3,
"Thyroid metastases":1,
"computed tomography (CT)":1,
"imaging findings":1,
"magnetic resonance imaging (MRI)":1,
"prevalence":3,
"ultrasound":12,
"Dual energy computed tomography (DECT)":1,
"enhancement":1,
"pulmonary nodules":1,
"wash-in/out":1,
"endoscopic":2,
"quality of life":2,
"thyroidectomy":11,
"Epidemiology":8,
"Surveillance":4,
"and End Results (SEER)":2,
"head and neck squamous cell carcinoma":1,
"survival":8,
"BRAF":5,
"liquid-based preparation":1,
"methylation":4,
"papillary carcinoma":7,
"diffusion-weighted MRI":1,
"textural analysis":1,
"thyroid tumors":2,
"bilateral axillo-breast approach":1,
"difficulty":1,
"robotic thyroidectomy":4,
"thyroiditis":1,
"oropharynx neoplasm":1,
"papillary thyroid cancer":14,
"retropharyngeal space":1,
"transoral robotic surgery":1,
"BRAFV600E mutation":3,
"Hashimoto' s thyroiditis":1,
"aggressive factors":1,
"protective factor":1,
"Cancer incidence":4,
"Cancer survival":1,
"Health numeracy":1,
"Perception":1,
"Worry":1,
"clinical presentation":1,
"fine-needle aspiration (FNA)":1,
"incidentaloma":1,
"Core needle biopsy (CNB)":1,
"Galectin-3":1,
"Nodule":2,
"Conventional thyroidectomy":1,
"Swallowing":1,
"Total thyroidectomy":6,
"Transaxillary approach":1,
"Voice":2,
"Korea":3,
"Rural population":1,
"Urbanization":1,
"Anaplastic thyroid cancer":4,
"Core needle biopsy":2,
"Fine needle aspiration":7,
"Thyroid lymphoma":2,
"Thyroid nodule":15,
"Clinicopathological parameters":1,
"Ephrin receptors":1,
"Hyperplastic nodule":1,
"Immunohistochemistry":10,
"Thyroid malignancy":2,
"lymph node status":1,
"prognostic factor":1,
"recurrence":8,
"BRAF mutation":2,
"central lymph node metastasis":2,
"tumor size":1,
"Bethesda System for Reporting Thyroid Cytopathology (BSRTC)":1,
"National Cancer Institute (NCI)":1,
"atypia of undetermined significance (AUS)":1,
"follicular lesion of undetermined significance (FLUS)":1,
"malignancy risk":2,
"fine-needle aspiration biopsy (FNAB)":1,
"learning curve":1,
"surgeon":1,
"BRAF-activated long noncoding RNA":1,
"Long noncoding RNA":2,
"Thyroid neoplasms":13,
"cancer death":1,
"disease-specific death":1,
"nomogram":1,
"predicting recurrence":1,
"thyroid carcinoma":16,
"follicular thyroid carcinoma":3,
"radiotherapy":7,
"review":2,
"Diagnostic":1,
"FOXE1":1,
"Follicular thyroid lesion":1,
"PAX8":1,
"TTF-1":2,
"Thyroid nodules":8,
"T2* mapping":1,
"T2* value":1,
"Nodule growth":1,
"Thyroid nodules 5–10&nbsp":1,
"mm":1,
"Cancer survivorship":1,
"Employment":1,
"Population-based study":1,
"Work":1,
"Second cancer":1,
"overdiagnosis":1,
"papillary microcarcinomas":1,
"thyroid cancer epidemic":1,
"Cyclooxygenase-2":1,
"EP4 receptor":1,
"Microsomal prostaglandin E synthase-1":1,
"Prostaglandin E2":1,
"ETS1":1,
"Integrin β6":1,
"Invasiveness":1,
"PDAC":1,
"Prognostic indicator":1,
"Adriamycin":1,
"Breast cancer":22,
"Chemotherapy":6,
"Drug resistance":1,
"Exosomes":1,
"MicroRNAs":1,
"risk factor":1,
"thyroid isthmusectomy":1,
"CCR6":1,
"Chemokine receptor":1,
"Thyroid cancer cell lines":1,
"Tumor necrosis factor-α":1,
"diagnostic lobectomy":1,
"fine-needle aspiration":6,
"follicular variant":2,
"sensitivity of fine-needle aspiration":1,
"follicular carcinoma":1,
"mucin":1,
"Clinical management":1,
"Consenso español":1,
"Cáncer diferenciado de tiroides":1,
"Differentiated thyroid cancer":7,
"Manejo clínico":1,
"Radioactive iodine refractory":1,
"Refractario al yodo radioactivo":1,
"Spanish consensus":1,
"Revision thyroid surgery":1,
"Tg":1,
"complications":1,
"safety":3,
"thyroglobulin":3,
"Advanced spectral imaging":1,
"Duel-energy computed tomography":1,
"Intranodular hemorrhage":1,
"Material decomposition":1,
"cutoff value":1,
"serum thyroglobulin":1,
"washout thyroglobulin":1,
"ACP = adamantinomatous craniopharyngioma":1,
"ASPS = arachnoidal sleeve around the pituitary stalk":1,
"BMI = body mass index":1,
"CP = craniopharyngioma":1,
"HSS = hypothalamic status score":1,
"OS = overall survival":1,
"PCP = papillary craniopharyngioma":1,
"PFS = progression-free survival":1,
"TSH = thyroid-stimulating hormone":2,
"TVF = third ventricle floor":1,
"classification":1,
"craniopharyngiomas":1,
"growth pattern":1,
"oncology":2,
"pituitary stalk":1,
"Biopsy, fine-needle":1,
"Frozen sections":1,
"Thyroid gland":5,
"Ultrasonography":8,
"Doppler US":1,
"resistance index":1,
"vasculature":1,
"Ansa cervicalis nerve":1,
"Great auricular nerve":1,
"Hoarseness":1,
"Nerve reconstruction":1,
"Recurrent laryngeal nerve paralysis":1,
"Antiangiogenic therapy":2,
"Clear cell renal carcinoma":1,
"Glandular metastases":1,
"Kidney cancer":1,
"Prognosis factors":1,
"Survival outcome":1,
"Targeted therapies":2,
"Adenomatous polyposis coli":1,
"Cribriform–morular variant of papillary thyroid cancer (CMV-PTC)":1,
"Familial adenomatous polyposis":2,
"Hispanics":1,
"β-Catenin":3,
"Autoimmune disease":1,
"Autoimmunity":1,
"Hyperprolactinemia":1,
"Prolactin":1,
"Prolactinoma":1,
"Ectopic thyroid tissue":1,
"Surgery":6,
"Fine needle cytology":1,
"Hurthle cells":1,
"Benign multinodular goiter":1,
"Dunhill procedure":1,
"Goiter recurrence":1,
"Post-operative complications":1,
"Subtotal thyroidectomy":1,
"Cytology":3,
"Incidental carcinoma":1,
"Lobectomy":1,
"THY3":1,
"Airway":1,
"Locally invasive":1,
"Multimodality":1,
"Trachea":1,
"Inferior thyroid artery":1,
"Multinodular goiter":1,
"meta-analysis":6,
"parity":1,
"risk":1,
"follicular":1,
"papillary":3,
"radiation":4,
"extrathyroidal extension":1,
"optical coherence tomography":1,
"Cervico-mediastinal goiter":1,
"Cervicosternotomy":1,
"Cervicotomy":1,
"Goiter":2,
"Intrathoracic thyroid mass":1,
"Lamin A/C":1,
"Metastasis":12,
"Progerin":1,
"Tumor marker":1,
"Stomatin-like protein 2":1,
"tumor progression":1,
"111In-Octreotide SPECT":1,
"18F-FDG-PET/CT":1,
"Contrast-enhanced CT":1,
"Medullary thyroid carcinoma":6,
"Multimodal imaging":1,
"completion thyroidectomy":1,
"hypoparathyroidism":3,
"sensitivity":1,
"specificity":1,
"ultrasound characteristics":1,
"neurotrophic tyrosine kinase":1,
"pediatric cancer":1,
"receptor type 3/ets variant 6 (NTRK3/ETV6) fusion oncogene":1,
"ATA risk stratification":2,
"TNM staging":4,
"distant metastasis":2,
"nodal metastasis":1,
"AKT":2,
"MAPK":2,
"MED27":1,
"Melanoma":2,
"NF-κB":1,
"iNOS":1,
"Fukushima":1,
"radiation exposure":2,
"thyroid cyst":1,
"thyroid ultrasound screening":1,
"Invasive mucinous adenocarcinoma":1,
"KRAS":2,
"Lung cancer":3,
"NKX2-1":2,
"Cervical lymph nodes":1,
"Needle Tract Seeding":1,
"Salivary glands":1,
"Androgen independence":1,
"Cell biology":1,
"Phosphorylation":1,
"Prostate cancer":3,
"THRAP3":1,
"EASYPREP":1,
"cytological techniques":1,
"fine-needle aspiration biopsy":3,
"United States":1,
"adolescent":1,
"young adult":1,
"proteomics":2,
"telomerase":1,
"Gerotarget":2,
"age":1,
"cervical cancer":2,
"envelope":1,
"human endogenous retrovirus K":1,
"medullary":1,
"multiple endocrine neoplasia (MEN)":1,
"parathyroid":1,
"database":1,
"RECIST 1 0":1,
"RECIST 1 1":1,
"target lesion":1,
"targeted agent":1,
"tumor response":1,
"National Cancer Data Base":2,
"patterns of care":1,
"biopsy":4,
"fine needle":1,
"large-core needle":1,
"ARID1A":1,
"BEAS-2B cells":1,
"PTEN":1,
"miR-222":1,
"tumor growth":1,
"EIF1AX":1,
"FNA":1,
"follicular adenoma":1,
"BET":1,
"MCM5":1,
"RNA-seq":1,
"epigenetics":1,
"conventional papillary thyroid cancer":1,
"follicular variant of papillary thyroid cancer":1,
"incidence rate":1,
"incidence trend":1,
"DACT2":1,
"Wnt signaling":1,
"esophageal cancer":1,
"Climacteric":1,
"Medical condition":1,
"Menopausal symptoms":1,
"Menopause":1,
"Middle-age":1,
"EDAG-1":1,
"MAPK/Erk":1,
"SW579 cells":1,
"invasion":6,
"proliferation":6,
"BRAF resistance":1,
"colchicine":1,
"high throughput drug screening":1,
"BRAF V600E mutation":2,
"TERT promoter mutation":1,
"molecular marker":1,
"prognosis":11,
"BRAF(V600E)":2,
"CLNM":1,
"PTC":1,
"lymph nodes":3,
"neck":1,
"neck dissection":4,
"outcomes":1,
"radioactive iodine":6,
"HCC":3,
"PKM2":4,
"PTPN6":1,
"SHP-1":1,
"nondiagnostic cytology":1,
"B-Raf(V600E)":1,
"colorectal cancer":3,
"ChIP-on-chip":1,
"ELF2":1,
"cell growth":2,
"thyroid hormone receptor":1,
"head and neck ultrasound":3,
"histogram analysis":1,
"sonography":2,
"ALDH1":1,
"Chemoresistance":3,
"Stem cell":1,
"Subtype":1,
"bladder cancer":1,
"precancerous":1,
"tumorigenesis":2,
"urothelium":1,
"Doppler ultrasound":1,
"TIRADS":1,
"cystic-like thyroid nodule":1,
"mummy":1,
"thyroid nodule shrinkage":1,
"Aurora kinase":1,
"Cell motility":1,
"Cofilin-1":1,
"4-Hydroxytamoxifen":1,
"Curcumin":1,
"Hexokinase-2":1,
"SLUG":1,
"Anti-cancer drug":1,
"PKM1":1,
"Warburg effect":1,
"Spinal":1,
"angiography":1,
"cervical":1,
"embolization":1,
"preoperative":1,
"Taiwan":1,
"diabetes mellitus":2,
"sitagliptin":1,
"2016":1,
"Forecasting":1,
"Incidence":4,
"Mortality":3,
"Neoplasms":3,
"VEGF":2,
"adverse effects":1,
"angiogenesis":1,
"tumor":2,
"Breast neoplasm":1,
"Molecular subtype":1,
"Tumor location":1,
"Apoptotic cell death":1,
"BCL-2 inhibitor":1,
"Dedifferentiated thyroid carcinoma":1,
"epidural spinal cord compression":1,
"freedom from recurrence":1,
"functional outcomes":1,
"irradiation":1,
"caveolin-1":1,
"growth":2,
"matrix metalloproteinases":1,
"pathway studio":1,
"random positioning machine":1,
"simulated microgravity":1,
"vascular endothelial growth factor":1,
"18F-fluorodeoxyglucose positron emission tomography/computed tomography":1,
"differentiated thyroid carcinoma":6,
"metastasization":1,
"tumour recurrence":1,
"Transwell chamber assay":1,
"lysine-specific demethylase 1":1,
"small interfering RNA":1,
"soft agar colony formation assay":1,
"adenosquamous carcinoma":1,
"diagnosis":9,
"thyroglossal duct cyst":1,
"treatment":3,
"B-RafV600E mutation":1,
"clinicopathological characteristics":1,
"detection":1,
"cervical low incision":1,
"classic ‘L’ incision":1,
"eight reserved":1,
"thyroid papillary carcinoma":2,
"Excess risk":1,
"gender differences":1,
"population-based":1,
"registries":1,
"relative survival":1,
"sex hormones":1,
"survival analysis":1,
"Age-period-cohort analysis":1,
"Shanghai":1,
"Time trend":1,
"lifestyle":1,
"smoking":1,
"Breast carcinoma":1,
"radiotherapy (RT)":1,
"soft tissue":1,
"upper extremity":1,
"Cancer":14,
"Microcarcinoma":3,
"Bronchoscopy":1,
"Central airways":1,
"Metallic stents":1,
"Kidney":2,
"malignancy":3,
"transplantation":1,
"Cushing’s syndrome":1,
"ectopic ACTH secretion":1,
"expression":1,
"miRNA":1,
"Radiofrequency ablation":1,
"removal":1,
"MoS2 nanosheets":1,
"breast tumor":1,
"in vivo":1,
"photothermal regression":1,
"soybean phospholipid":1,
"RET":3,
"advanced thyroid cancer":1,
"targeted therapy":2,
"tyrosine kinase inhibitors":1,
"Eyelid":1,
"Hashimoto's thyroiditis (HT)":1,
"concurrent lesions":1,
"medullary thyroid carcinoma (MTC)":1,
"Stereotactic Radiosurgery":1,
"brain metastasis":1,
"dynamic conformal arc therapy":1,
"intramedullary spinal cord metastases":1,
"simultaneous integrated boost":1,
"spine metastasis":1,
"stereotactic radiotherapy":1,
"true beam s tx":1,
"volumetric modulated arc therapy (vmat)":1,
"Chernobyl":2,
"Fukushima Childhood cancer":1,
"nuclear fallout":1,
"Ectopic thyroid":2,
"midline ectopic thyroid":1,
"submandibular ectopic thyroid":1,
"18F-FDG":1,
"PET scan":1,
"second primary":1,
"Epithelial-mesenchymal transition":2,
"Leptin":2,
"Pyruvate kinase M2":1,
"Dual malignancy":1,
"dysgerminoma":1,
"papillary carcinoma of thyroid (PTC)":1,
"Hashimoto's disease":1,
"surgical treatment":2,
"carcinoma, papillary":1,
"TSH":2,
"pregnancy":2,
"Diabetes":1,
"Endoplasmic Reticulum Stress":1,
"Islet":1,
"Thyroid Hormone":1,
"Ovarian hyperstimulation":1,
"Positron emission tomography/computed tomography scan":1,
"Recombinant human thyrotropin":2,
"Rac1":1,
"adenocarcinoma":2,
"miR-101":1,
"migration":4,
"Minimal invasive thyroid surgery":1,
"anterior mini insicion":1,
"thyriodectomy":1,
"thyroid disease":1,
"cosmetic issues":1,
"laser ablation":1,
"pressure symptoms":1,
"thyroid benign nodules":1,
"ultrasound-guided interventional procedures":1,
"Cancer stem cells":2,
"Eribulin":1,
"Fulvestrant":1,
"Tamoxifen":3,
"Adjuvant endocrine therapy":2,
"Disease-free survival (DFS)":1,
"Leuprorelin acetate":1,
"Premenopausal endocrine-responsive breast cancer":1,
"Cysteine-rich protein 61":1,
"Epidermal growth factor":1,
"UbcH10":1,
"cetuximab":1,
"irinotecan":1,
"needle core biopsy":1,
"nephrectomy":1,
"EZ-VANS":1,
"Endoscopic thyroidectomy":1,
"E·Z-access":1,
"Lap-protector":1,
"AZD1152":1,
"Aurora kinase inhibitors":1,
"Cell cycle":1,
"MLN8237":1,
"Medullary thyroid cancer":3,
"TT cell line":1,
"Adenoid cystic carcinoma":1,
"FISH":1,
"fluorescence PCR":1,
"solid cell nest":1,
"thyroid remnants":1,
"Indeterminate cytology":1,
"Strain ratio":2,
"Thy3 thyroid nodules":1,
"Ultrasound strain elastography":1,
"automation":1,
"biological markers":1,
"digital pathology":1,
"image analysis":1,
"reproducibility":1,
"contrast-enhanced ultrasonography":1,
"Cadmium":1,
"Heavy metals":1,
"Trace elements":1,
"Zinc":1,
"cost-effectiveness":1,
"markov model":1,
"mastectomy":1,
"Scoring system":1,
"Follow-up":2,
"Internet":1,
"Survivorship":1,
"Technology":1,
"Head and neck surgery":1,
"laryngeal cancer":1,
"reconstruction":1,
"radiation therapy":2,
"NRAS oncogene":1,
"dialysis":1,
"epidemiology and outcomes":1,
"kidney transplantation":1,
"FOXR2":1,
"Prognostic biomarker":1,
"Bleomicina":1,
"Bleomycin":1,
"Câncer de cabeça e pescoço":1,
"Electrochemotherapy":1,
"Eletroquimioterapia":1,
"Head and neck cancer":3,
"Palliative therapy":1,
"Terapia paliativa":1,
"Tireoide":1,
"Primary thyroid lymphoma":1,
"Ror2":1,
"Wnt5a":1,
"124I PET/CT":1,
"131I":1,
"Biomarker":2,
"lncRNA":1,
"AP-1":1,
"P85α":1,
"PDCD4":1,
"ROC curve":1,
"Asian American":1,
"disparities":1,
"Molecular targets":1,
"Nanodevices":1,
"Re-differentiation strategies":1,
"131I therapy":1,
"Taiwan National Health Insurance Database":1,
"TIR3":1,
"expression analysis":1,
"Atypia of undetermined significance":3,
"cytopathology":2,
"follicular lesion of undetermined significance":2,
"Salt-inducible kinase 1":1,
"Silencing mediator for retinoid":1,
"Thyroid receptors":1,
"Twist1":1,
"mRNA in situ hybridization":1,
"non-small cell lung cancer":1,
"thyroid transcription factor-1":1,
"tissue microarray":2,
"BRAF mutation test":1,
"DNA degradation":1,
"conventional smear":1,
"liquid-based cytology":2,
"Childhood radiation exposure":1,
"Paediatric thyroid carcinoma":1,
"BRAFV600E":1,
"MEK inhibition":1,
"cancer stem cell":2,
"microrna":4,
"pluripotency":1,
"resistance":2,
"3D endoscopy":1,
"Craniopharyngioma":1,
"Endoscopic endonasal surgery":1,
"Pituitary adenoma":3,
"Rathke cleft cyst":1,
"Transsphenoidal approach":1,
"disease recurrence":1,
"disease-free survival":1,
"Four-dimensional computed tomography":1,
"Hyperparathyroidism":1,
"Parathyroid adenoma":3,
"Volume":1,
"Leukemia":1,
"Lymphoma":1,
"Solid cancer":1,
"Standardized Incidence Ratio (SIR)":1,
"Autoimmune diseases":1,
"Coeliac disease":1,
"Comorbidity":1,
"Bethesda category":1,
"Conventional subtype":1,
"ECM1":1,
"TMPRSS4":1,
"VDR":1,
"Psammoma body":1,
"Ultrasound fine-needle aspiration biopsy":1,
"von Kossa stain":1,
"Bethesda category III":1,
"malignancy rates for AUS/FLUS":1,
"repeat FNAB for initial AUS/FLUS category":1,
"intermediate-risk":1,
"radioactive iodine ablation":2,
"sphingosine-1-phosphate":1,
"Elastography":2,
"Hashimoto’s thyroiditis":4,
"Papillary thyroid microcarcinoma":4,
"TPO-Ab":1,
"National Program of Cancer Registries (NPCR)":1,
"North American Association of Central Cancer Registries (NAACCR)":1,
"liver cancer":1,
"trends":1,
"viral hepatitis":1,
"Embolic agents":1,
"Embosphere":1,
"Hypervascular tumors":1,
"Transcatheter arterial embolization":1,
"Trisacryl gelatin microspheres":1,
"telomerase reverse transcriptase (TERT) promoter mutations":1,
"Hypothyroidism":4,
"Hereditary cancer":1,
"Mucocutaneous pigmentations":1,
"Peutz-Jeghers syndrome":1,
"Polyposis":1,
"STK11":1,
"DICER-1":1,
"Pleuropulmonary blastoma":1,
"Sertoli-Leydig cell tumor":1,
"familial neoplasia":1,
"annual percent change":1,
"average annual percent change":1,
"delay adjustment":1,
"early estimates of cancer incidence rates":1,
"population-based registry data":1,
"Goitre ovarien":1,
"Kyste ovaire":1,
"Ovarian cyst":1,
"Struma ovarii":1,
"Thyroïde":1,
"brain":2,
"breast":1,
"fluoroscopically guided interventional procedures":1,
"interventional radiology":1,
"radiologic procedures":1,
"attitudes":1,
"physician":1,
"second opinion":1,
"Contralateral carcinoma":1,
"Papillary microcarcinoma":1,
"Surgical strategy":1,
"Radiofrequency":1,
"Anaplastic thyroid carcinoma":2,
"Postoperative radiotherapy":1,
"Systematic review":1,
"Biological dosimetry":1,
"Cytogenetic damage in lymphocytes":1,
"Micronucleus assay":1,
"Radioiodine therapy":3,
"Virtual Touch tissue imaging":1,
"acoustic radiation force impulse":1,
"area ratio":1,
"Pembrolizumab":2,
"Programmed death-ligand 1":2,
"U S Food and Drug Administration":1,
"BRCA1":1,
"pyrosequencing":1,
"Calcitriol":1,
"cancer stem-like cells":1,
"ABI3":1,
"DNA methylation":1,
"cancer-specific differentially methylated region (cDMR)":1,
"microRNA-375":1,
"vandetanib":1,
"Hypoxia":2,
"Stem cell niche":1,
"Stemness":1,
"ATF3":1,
"TR4":1,
"TR4 response element":1,
"hepatocellular carcinoma":4,
"OB3-leptin peptide":1,
"cancer cell invasion":1,
"obesity":2,
"Children":1,
"Neoplasia":1,
"Turner syndrome":1,
"X-chromosome":1,
"kinases":1,
"screening":1,
"siRNA":1,
"BER":1,
"Differentiated thyroid cancer risk":1,
"NER":1,
"Polymorphism":1,
"Undifferentiated thyroid carcinoma":1,
"miR-126":1,
"Testicular cancer":1,
"genetics":1,
"clonal origin":1,
"exome sequencing":1,
"field cancerization":1,
"multifocality":1,
"tumour evolution":1,
"diagnostic biomarker":1,
"growth factors":1,
"proNGF":1,
"CCR3":1,
"luminal-like":1,
"peritumoral":1,
"relapse-free survival":1,
"benign nodule":2,
"protein biomarkers":1,
"subcellular localization":1,
"gene expression profile":1,
"microenvironment":1,
"oncogenes":1,
"complication":1,
"CK1α":1,
"DNA binding":1,
"MDMX":1,
"p53":1,
"secondary interaction":1,
"side population":1,
"metastases":2,
"Frozen section":1,
"metabolism":2,
"CD147":1,
"CD326":1,
"CRC":1,
"BRAF V600E":2,
"KRAS G12D":1,
"kinase inhibitor":1,
"papillary thyroid cancer (PTC)":1,
"Apoptosis":3,
"miR-486-5p":1,
"Ablation techniques":1,
"Multidetector computed tomography":1,
"fluorodeoxyglucose-positron emission tomography/computed tomography":1,
"iodine-131(131I) whole body scintigraphy":1,
"radioiodine scan":1,
"Bethesda II":1,
"McGill Thyroid Nodule Score":1,
"Nodule size":1,
"Ultrasound-guided fine needle aspiration biopsy":1,
"ubiquitin-specific protease 22":1,
"EMT":1,
"LOX":1,
"bisphosphonates":1,
"estrogen recepter":1,
"MEN1":1,
"MEN2":1,
"MEN4":1,
"Multiple endocrine neoplasia":1,
"Neuroendocrine tumor":3,
"Anthropometric parameters, thyroid function, biochemical parameter, chronic hepatitis C virus, non-response patients, chloroquine,":1,
"Lymph node neck dissection":1,
"Routine central lymph node dissection":1,
"Goserelin":1,
"Ovarian function suppression":1,
"Premenopause":1,
"Intramedullary spinal cord metastasis":1,
"laminectomy":1,
"spinal metastasis":1,
"anatomical resection":1,
"hepatectomy":1,
"intrahepatic recurrence":1,
"liver cirrhosis":1,
"nonanatomical resection":1,
"Microangiopathic hemolytic anemia (MAHA)":1,
"Thorombotic microangiopathy (TMA)":1,
"Dosimetry":2,
"Iodine radioisotopes/therapeutic use":1,
"Radioisotopes/pharmacokinetics":1,
"KDR":1,
"Lung adenocarcinoma":2,
"Screening cascade":1,
"Selectivity":1,
"multifocal":1,
"Gefitinib":1,
"epidermal growth factor receptor (EGFR)":1,
"hepatocarcinogenesis":1,
"intraportal transplantation":1,
"head/neck":1,
"drug delivery systems":1,
"human thyroid carcinoma":1,
"nanoliposomes":1,
"phosphodiesterase-5 (PDE5) inhibitors":1,
"areola approach":1,
"Diffuse large B-cell lymphoma":1,
"Flow cytometry":1,
"Lymphocytic thyroiditis":1,
"MALT lymphoma":1,
"alternative splicing":1,
"antigen":1,
"thyroid autoimmunity":1,
"thyroid peroxidase":1,
"Laryngeal location":1,
"leczenie chirurgiczne":1,
"lokalizacja krtaniowa":1,
"tarczyca ektopowa":1,
"Warthin-like variant":1,
"clinicopathological feature":1,
"mimicking":1,
"tuberculosis":1,
"Acetate":1,
"PET-CT":1,
"Physiologic distribution":1,
"Pitfalls":1,
"fine-needle":1,
"histology":1,
"positron emission tomography":3,
"carbon nanoparticles":1,
"clinically node-negative patients":1,
"retrospective analysis":1,
"Metastatic renal cell cancer":1,
"Sunitinib":2,
"Extrathyroid invasion":1,
"branchial cyst":1,
"cervical sinus":1,
"iodine deficiency":1,
"thyroid goiter":1,
"Central lymph node":1,
"Globus":1,
"GPx":1,
"GSH":1,
"LPO":1,
"Oxidative stress":1,
"catalase":1,
"thyroid goitre":1,
"IMRT":1,
"Palliative care":1,
"RTOG 8502":1,
"Pericardial effusion":1,
"Pleural effusion":1,
"Renal cell carcinoma":2,
"Minimally invasive video-assisted thyroidectomy (MIVAT)":1,
"benign lesion":1,
"thyroid cytology":1,
"ACTH = adrenocorticotropic hormone":1,
"FSH = follicle-stimulating hormone":1,
"GH = growth hormone":1,
"IDH1 = isocitrate dehydrogenase 1":1,
"IDH2 = isocitrate dehydrogenase 2":1,
"LH = luteinizing hormone":1,
"MEN1 = multiple endocrine neoplasia 1":1,
"Maffucci syndrome":1,
"PCR = polymerase chain reaction":1,
"PNA = peptide nucleic acid":1,
"PRL = prolactin":1,
"RET = rearranged during transfection":1,
"SDH = succinate dehydrogenase":1,
"isocitrate dehydrogenase":1,
"somatic mosaicism":1,
"Fine needle aspiration cytology":2,
"Intercalated duct adenoma":1,
"Intercalated duct hyperplasia":1,
"Intercalated duct lesion":1,
"Parotid":1,
"Salivary gland":1,
"Head and neck malignancies":1,
"Simultaneous":1,
"Triple primary malignancies":1,
"18F-DOPA":1,
"Neuroendocrine tumours":2,
"endoscopic surgery":2,
"robotic surgery":1,
"surgical outcomes":1,
"Childhood cancer survivorship":1,
"Health services":1,
"Healthcare access":1,
"Long-term follow-up care":1,
"Coagulación":1,
"Coagulation":1,
"Tiroides":1,
"differential diagnosis":1,
"poorly differentiated thyroid carcinoma":2,
"Prediction":1,
"Iodine-124":1,
"PET/CT":1,
"PET/MRI":1,
"TGFβ1":1,
"miR-663":1,
"Autoantibodies":1,
"Immunoassay":1,
"Time-resolved":1,
"Differentiated thyroid cancer (DTC)":1,
"Young":1,
"99mTc-MIBI":1,
"Fine-needle aspiration cytology":1,
"Follicular neoplasms":2,
"Molecular markers":1,
"Mutation analysis":1,
"Scintigraphy":1,
"Cervical lymph node metastasis":1,
"NCDB":1,
"Prophylactic lymph node dissection":1,
"Predictor":1,
"Glycolysis":1,
"Hexosamine biosynthetic pathway":1,
"Neoadjuvant chemotherapy":1,
"Pentose phosphate pathway":1,
"Prognostic and predictive value":1,
"Cancer-associated fibroblast":1,
"Anti-Tg antibody":1,
"Radioiodine ablation":2,
"Fukushima risk assessment":1,
"Japanese A-bomb survivors":1,
"Radiation epidemiology":1,
"Risk models":1,
"Body mass index":1,
"Overweight":1,
"Provox 2":1,
"Provox Vega":1,
"alaryngeal speech":1,
"device life":1,
"laryngectomy":1,
"tracheoesophageal voice prosthesis":1,
"columnar cell variant of papillary carcinoma":1,
"Clinical outcome":1,
"Radioactive iodine therapy":2,
"Thyrotropinoma":1,
"hysterectomy":1,
"registry-based":1,
"FDG-PET/CT":1,
"iodine negative":1,
"follicular adenomas":1,
"follicular carcinomas":1,
"cataract":1,
"iodine radioisotopes":1,
"CD11c":1,
"CD206":1,
"polarization":1,
"tumour-associated macrophages":1,
"insular carcinoma":1,
"rare thyroid cancer":1,
"NSCC":1,
"Pathology":2,
"p40":1,
"and End Results (SEER)-Medicare":1,
"Gastric cancer":2,
"Jmjd1a/KDM3A":1,
"NuRD":1,
"Oct1/POU2F1":1,
"Carcinogenesis":4,
"High throughput screening":1,
"Prediction modeling":1,
"dose adjustment":1,
"hepatic impairment":1,
"lenvatinib":1,
"pharmacokinetics":2,
"pooled analysis":1,
"population":2,
"Fine needle aspiration biopsy":1,
"Inadequate material":1,
"Biomolecular sensing":1,
"Human Thyroglobulin (TG) detection":1,
"Label-free detection":1,
"Long period fiber grating (LPG)":1,
"Optical fiber biosensor":1,
"Reflection-type LPG":1,
"GATA-3":1,
"ductal carcinoma of the breast":1,
"Androgen receptor (AR)":1,
"Bromodomain containing 8 (BRD8)":1,
"miR-185":1,
"Anastrozole":1,
"hormone-sensitive tissues":1,
"isoflavones":1,
"menopausal hot flushes":1,
"Pediatric thyroid cancer":1,
"TERT":1,
"Well differentiated thyroid carcinoma":1,
"HMGB1":1,
"Macrophage migration inhibitory factor (MIF)":1,
"TLR4":1,
"Mutations":1,
"Radiation risk":1,
"Radiobiology":1,
"Stem cells":1,
"Diagnostic markers":1,
"Epigenetic":1,
"let7":1,
"miRNAs":2,
"Adult Lhermitte–Duclos disease":1,
"Cowden syndrome (CS)":1,
"Hamartomas":1,
"Mucosal papillomatosis":1,
"Multiple neoplasms":1,
"PTEN hamartoma tumor syndrome (PHTS)":1,
"Phosphatase and tensin homolog (PTEN) gene":1,
"Thyroid adenomatous nodules":1,
"Trichilemmomas":1,
"Lymph node":2,
"Shear wave elastography":1,
"lateral neck dissection":1,
"robotic neck dissection":1,
"selective neck dissection":1,
"gasless unilateral axillary approach":1,
"postauricular facelift approach":1,
"hyperlipidemia":1,
"tyrosine kinase inhibitor":1,
"Anti-PD-1 therapy":1,
"PD-L1":1,
"Phase I study":1,
"cell line":1,
"gene expression":2,
"molecular biology":1,
"tall cell":1,
"Epithelioid hemangioendothelioma":1,
"Sarcoma":1,
"Vascular":1,
"WWTR1-CAMTA1":1,
"thyroid FNA":1,
"Biomedicine":1,
"Cytological smear":1,
"MALDI-imaging":1,
"Mass spectrometry":1,
"late effects":1,
"pediatric":2,
"secondary malignancy":1,
"Benign larynx neoplasm":1,
"Larynx disease":1,
"Solitary fibrous tumour":1,
"FNAC":1,
"histopathology":3,
"primary giant cell tumor of parotid gland":1,
"Hydrocephalus":1,
"H19":1,
"YES1":1,
"competing endogenous RNA":1,
"microRNA-17-5p":1,
"AKT1 mutations":1,
"Proteus syndrome":1,
"somatic mutation":1,
"Cancers":1,
"Chernobyl nuclear accident":1,
"Disaster relief planning":1,
"Psychological effects":1,
"Radiation effects":1,
"Radiation induced":1,
"BRAF inhibitors":1,
"MEK inhibitors":1,
"Radioiodine refractory thyroid cancer":1,
"Small-molecule tyrosine kinase inhibitors":1,
"autophagy":1,
"lysosomes":1,
"necrosis":1,
"obatoclax":1,
"5-FU":1,
"APE1":1,
"AT101":1,
"Her-2 positive":1,
"metformin":1,
"mouse models":1,
"thyroid carcinogenesis":1,
"Gene transcription":1,
"Nuclear receptor corepressor 1":1,
"acoustic radiation force impulse imaging":1,
"HKDC1":1,
"thyroid stimulating hormone":1,
"Levator glandulae thyroideae":1,
"Lobe of Lalouette":1,
"Pyramidal lobe":1,
"Sodium iodide symporter":1,
"cytotoxic chemotherapy":1,
"multitargeted kinase inhibitors":1,
"personalized therapy":1,
"hyperparathyroidism-jaw tumor (HPT-JT)":1,
"malignant tumor":1,
"multiple endocrine neoplasia type 1 (MEN1)":1,
"multiple endocrine neoplasia type 2A (MEN2A)":1,
"Corticosteroid":1,
"Drug-induced liver injury (DILI)":1,
"Iodine-131":1,
"SphK2":1,
"miR-613":1,
"childhood cancer survivors":1,
"endocrine-related cancer":1,
"secondary malignant neoplasms":1,
"Central lymph node metastasis (CLNM)":1,
"Differentiated thyroid carcinoma (DTC)":1,
"Prophylactic central neck dissection (pCND)":1,
"Recurrence risk stratification (RRS)":1,
"Risk factors":2,
"Risk-stratification":1,
"Staging":1,
"Therapy":3,
"ELISA":1,
"extracellular vesicle":1,
"Cysts":1,
"Neurocysticercosis":1,
"bias (epidemiology)":1,
"causality":1,
"type 2 diabetes mellitus":1,
"estrogen receptor alpha":1,
"ras":1,
"senescence":1,
"transformation":1,
"SEER database":1,
"comparative effectiveness":1,
"propensity score":1,
"Surveys and questionnaires":1,
"Glycine":1,
"Serine":1,
"Mucinous carcinoma":1,
"Rhabdoid cells":1,
"TSH suppression":1,
"computed tomography":1,
"differential diagnoses":1,
"mandibular metastatic carcinoma":1,
"Biopsy fine needle":1,
"cytodiagnosis":1,
"infarction":1,
"minimally invasive thyroidectomy":1,
"neuromonitoring":1,
"P54":1,
"PAK4":1,
"cis-platinum":1,
"complete remission":1,
"liposomal doxorubicin":1,
"partial remission":1,
"calcitonin":1,
"multiple endocrine neoplasia type 2":1,
"leiomyosarcoma":1,
"hypercalcemia":1,
"parathyroid carcinoma":1,
"parathyroid hormone":1,
"parathyroid hormone-related protein":1,
"MPHOSPH8":1,
"shRNA":1,
"DNA repair":1,
"SNP":1,
"cell cycle regulator":1,
"molecular genetics":1,
"let-7 family":1,
"MAPK signaling pathway":1,
"RARB":1,
"Sodium-iodide symporter":1,
"miR-106a":1,
"Guideline":1,
"Brain tumor":1,
"Cerebral metastases":1,
"Epithelioid glioblastoma":1,
"Glioblastoma":1,
"Gliosarcoma":1,
"Rhabdoid meningioma":1,
"Neoplasm Recurrence, Local":1,
"Venous Thrombosis":1,
"Malignant struma ovarii":1,
"Paraganglioma":1,
"Pheochromocytoma":1,
"Single photon emission computed tomography-computed tomography":1,
"Single photon emission computed tomography/computed tomography":1,
"carcinoma":1,
"diarrhea":1,
"vandetanib treatment":1,
"E-cadherin":1,
"Cerebellar hemangioblastoma":1,
"Challenging diagnosis":1,
"Metastatic cerebellar tumor":1,
"Solid tumor":1,
"Yunnan plateau":1,
"autoimmune disease status":1,
"benign thyroid disease":1,
"adrenocortical neoplasm":1,
"borderline malignant potential":1,
"oncocytoma":1,
"hypopharynx":1,
"larynx":1,
"Urine iodine":1,
"Multinodular goitre":1,
"Thyroid disorders":2,
"Goitre":1,
"Hypocalcaemia":1,
"Multiple Endocrine Neoplasia syndrome":1,
"Whipple’s procedure":1,
"prophylactic central compartment dissection":1,
"radioiodine ablation treatment":1,
"Gardner syndrome":1,
"Turcot syndrome":1,
"CD56":1,
"HBME-1":1,
"Teratoma – diagnosis":1,
"Struma ovarii – diagnosis":1,
"Carcinoid tumor":1,
"Endoscope":1,
"Procedures":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年第2季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
